Pericapsular Nerve Group Block Versus Femoral Nerve Block Study

ConditionHip Fractures
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50+
SponsorTaksim Egitim ve Arastirma Hastanesi

About this trial

Hip fractures are common in older adults and are often associated with severe pain, making it difficult for patients to sit for spinal anesthesia before surgery. Peripheral nerve blocks may improve pain control and facilitate patient positioning, but it remains uncertain whether the Pericapsular Nerve Group (PENG) block provides advantages over the traditional femoral nerve block during the spinal anesthesia procedure.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adults aged 50 years or older.

Diagnosis of proximal femoral fracture.

Scheduled to undergo surgical repair under spinal anesthesia.

American Society of Anesthesiologists (ASA) physical status I-III.

Disqualifiers

Refusal to participate or inability to provide informed consent.

Coagulopathy or contraindication to spinal anesthesia or peripheral nerve block.

Local infection at the planned injection site.

Known allergy or hypersensitivity to local anesthetics.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Ultrasound-Guided Pericapsular Nerve Group (PENG) Block

    Procedure/Surgery

    Ultrasound-guided PENG block performed before spinal anesthesia using 20 mL of 0.25% bupivacaine to provide analgesia for patients undergoing surgery for proximal femur fracture.

  • Ultrasound-Guided Femoral Nerve Block

    Procedure/Surgery

    Ultrasound-guided femoral nerve block performed before spinal anesthesia using 20 mL of 0.25% bupivacaine to provide analgesia for patients undergoing surgery for proximal femur fracture.

  • Spinal Anesthesia (bupivacaine)

    Procedure/Surgery

    Standard spinal anesthesia performed after the assigned peripheral nerve block using intrathecal hyperbaric bupivacaine according to the study protocol.

Treatment groups

110 Participants
are divided into 2 treatment groups
Group A: PENG BlockActive comparator 2 interventions
Group B: Femoral Nerve BlockActive comparator 2 interventions

Trial outcomes

Primary outcomes

1

Spinal Anesthesia Convenience Score (SACS)

Spinal anesthesia convenience will be assessed using the Spinal Anesthesia Convenience Score (SACS), a composite clinical score evaluating the ease of spinal anesthesia based on anatomical landmark palpation, patient cooperation, sitting position quality, pain during passive hip flexion, and pain while maintaining the sitting position. Total scores range from 0 to 11, with higher scores indicating easier spinal anesthesia conditions.

Time frame
During spinal anesthesia procedure (immediately after patient positioning and before initiation of surgery)

Secondary outcomes

1

First-Attempt Success of Spinal Anesthesia

The proportion of participants in whom successful intrathecal access is achieved on the first needle insertion attempt.

Time frame
During the spinal anesthesia procedure.
2

Number of Spinal Needle Insertion Attempts

The total number of spinal needle insertion attempts required to achieve successful spinal anesthesia.

Time frame
During the spinal anesthesia procedure.
3

Duration of Spinal Anesthesia Procedure

Time from the beginning of patient positioning until completion of spinal anesthesia and return to the supine position, measured in minutes.

Time frame
During the spinal anesthesia procedure.
4

Anxiety Score

Patient anxiety will be assessed using an 11-point Numeric Rating Scale (NRS) ranging from 0 (no anxiety) to 10 (maximum anxiety). Lower scores indicate less anxiety.

Time frame
Before peripheral nerve block, 30 minutes after block placement, and immediately before surgical incision (after spinal anesthesia).

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.